TOPIC NOTES
Pharmacology
149 topics
TOPIC
A1: Cholinergic and adrenergic transmission and its presynaptic modification
コリン作動性・アドレナリン作動性伝達とそのシナプス前調節
TOPIC
A2: Cholinomimetics
コリン作動薬
TOPIC
A3: Muscarinic receptor blocking drugs
ムスカリン受容体遮断薬
TOPIC
A4: Catecholamines
カテコールアミン
TOPIC
A5: Indirect sympathomimetics. Selective α1 agonists
間接型交感神経刺激薬・選択的α1作動薬
TOPIC
A6: α2-agonists and drugs acting on the imidazoline receptors
α2作動薬およびイミダゾリン受容体作用薬
TOPIC
A7: α-receptor antagonists
α受容体拮抗薬
TOPIC
A8: β-receptor antagonists
β受容体拮抗薬
TOPIC
A9: Centrally and peripherally acting skeletal muscle relaxants
中枢性・末梢性骨格筋弛緩薬
TOPIC
A10: Local anesthetics
局所麻酔薬
TOPIC
A11: Opioids
オピオイド
TOPIC
A12: NSAIDs
非ステロイド性抗炎症薬(NSAIDs)
TOPIC
A13: Drugs used for treatment of gout. Drugs for headache syndromes
痛風治療薬・頭痛治療薬
TOPIC
A14: Inhalational anesthetics
吸入麻酔薬
TOPIC
A15: Intravenous anesthetics. Perioperative medication
静脈麻酔薬・周術期薬剤
TOPIC
A16: Benzodiazepines
ベンゾジアゼピン
TOPIC
A17: Non-benzodiazepine anxiolytics and non-benzodiazepine hypnotics
非ベンゾジアゼピン系抗不安薬・睡眠薬
TOPIC
A18: Antipsychotics
抗精神病薬
TOPIC
A19: Monoamine reuptake inhibitors
モノアミン再取り込み阻害薬
TOPIC
A20: Non-reuptake-inhibitor antidepressants. Agents used for treatment of manic phase of bipolar disorders
非再取り込み阻害型抗うつ薬・双極性障害躁状態治療薬
TOPIC
A21: Antiepileptics. Adjuvant analgesics
抗てんかん薬・鎮痛補助薬
TOPIC
A22: Drugs of neurodegenerative diseases (extrapyramidal motoric system, nootropic drugs)
神経変性疾患治療薬(錐体外路系・脳代謝賦活薬)
TOPIC
B1: Drugs influencing blood coagulation I: Antiplatelet agents. Fibrinolytic drugs. Drugs inhibiting bleeding
血液凝固に作用する薬I：抗血小板薬・線溶薬・止血薬
TOPIC
B2: Drugs influencing blood coagulation II: Anticoagulant drugs
血液凝固に作用する薬II：抗凝固薬
TOPIC
B3: Agents used in anemias
貧血治療薬
TOPIC
B4: Positive inotropic drugs
強心薬(陽性変力薬)
TOPIC
B5: Drugs influencing cardiac electrophysiology
心臓電気生理に作用する薬(抗不整脈薬)
TOPIC
B6: Drugs acting on the renin-angiotensin-aldosterone-system (RAAS)
レニン・アンジオテンシン・アルドステロン系(RAAS)作用薬
TOPIC
B7: Ca++-channel blockers and other vasodilators
カルシウム拮抗薬およびその他の血管拡張薬
TOPIC
B8: Drugs influencing the oxygen demand and oxygen supply of the heart. Drugs improving microcirculation
心臓の酸素需要・供給に作用する薬・微小循環改善薬
TOPIC
B9: Drugs affecting lipid metabolism. Drugs controlling body weight
脂質代謝に作用する薬・体重管理薬
TOPIC
B10: Potassium excreting (wasting) diuretics
カリウム排泄性利尿薬
TOPIC
B11: Potassium sparing diuretics, ADH antagonists, osmotic diuretics
カリウム保持性利尿薬・ADH拮抗薬・渗透圧利尿薬
TOPIC
B12: Glucocorticoids for oral and parenteral use
経口・非経口グルココルチコイド
TOPIC
B13: Mineralocorticoids. Topically applied glucocorticoids. Adrenocortical antagonists, inhibitors of corticosteroid synthesis
ミネラルコルチコイド・外用グルココルチコイド・副腰皮質拮抗薬及びステロイド合成阻害薬
TOPIC
B14: Androgens, anabolic steroids, antiandrogens. Agents affecting the sexual activity
アンドロゲン・蛋白同化ステロイド・抗アンドロゲン薬・性機能作用薬
TOPIC
B15: Estrogens and antiestrogens
エストロゲンおよび抗エストロゲン薬
TOPIC
B16: Progestins and antiprogestins. Contraceptives
プロゲスチン・抗プロゲスチン薬・避妊薬
TOPIC
B17: Thyroid and antithyroid drugs. Pituitary hormones. Hypothalamic hormones, hormonanalogs and antagonists
甲状腺・抗甲状腺薬・下垂体ホルモン・視床下部ホルモン及びその類似体・拮抗薬
TOPIC
B18: Pancreatic hormones and parenterally applied antidiabetic drugs
膵ホルモンおよび注射用抗糖尿病薬
TOPIC
B19: Oral antidiabetics
経口血糖降下薬
TOPIC
B20: Agents affecting bone mineral homeostasis (calcium, vitamin D, parathyroid hormone, calcitonin, etc.)
骨ミネラル恒常性に作用する薬(カルシウム・ビタミンD・副甲状腺ホルモン・カルシトニンなど)
TOPIC
B21: Selective β2-stimulants and other bronchodilators
選択的β2刺激薬およびその他の気管支拡張薬
TOPIC
B22: Antiinflammatory agents inhibiting bronchial inflammatory processes. Antitussive agents and expectorants
気管支抗炎症薬・鎮咳薬・去痰薬
TOPIC
B23: Drugs influencing gastric acid secretion, protective drugs of gastric mucosa
胃酸分泌に作用する薬・胃粘膜保護薬
TOPIC
B24: Antiemetic drugs. Prokinetic agents
制吐薬・消化管運動促進薬
TOPIC
B25: Drugs used in constipation (laxatives) and diarrhea. Drugs promoting digestion. Pharmacology of liver and biliary tract
便秘薬(下剤)・止瀧薬・消化促進薬・肝胆道系薬理
TOPIC
B26: Histamine and antihistamines
ヒスタミンおよび抗ヒスタミン薬
TOPIC
B27: Drugs acting on smooth muscles. Drugs influencing uterus contractions
平滑筋作用薬・子宮収縮作用薬
TOPIC
B28: Immunopharmacology I (cytotoxic agents)
免疫薬理学I(細胞傷害性薬)
TOPIC
B29: Immunopharmacology II (Inhibitors of cytokine gene expression, 5-ASA derivatives)
免疫薬理学II(サイトカイン遺伝子発現阻害薬・5-ASA誘導体)
TOPIC
B30: Immunopharmacology III (Antibodies and fusion proteins)
免疫薬理学III(抗体・融合タンパク質)
TOPIC
B31: Drugs used in cancer treatment I (antimetabolites)
抗がん薬I(代謝拮抗薬)
TOPIC
B32: Drugs used in cancer treatment II (cytotoxic agents targeting DNA)
抗がん薬II(DNA標的細胞傷害性薬)
TOPIC
B33: Drugs used in cancer treatment III (Topoisomerase inhibitors. Inhibitors of mitotic spindle)
抗がん薬III(トポイソメラーゼ阻害薬・紡錘体阻害薬)
TOPIC
B34: Drugs used in cancer treatment IV (Hormonal agents)
抗がん薬IV(ホルモン薬)
TOPIC
B35: Drugs used in cancer treatment V (Small molecule signal transduction inhibitors. Retinoids)
抗がん薬V(低分子シグナル伝達阻害薬・レチノイド)
TOPIC
B36: Drugs used in cancer treatment VI (Large molecule signal transduction inhibitors. Immunostimulant anticancer drugs)
抗がん薬VI(高分子シグナル伝達阻害薬・免疫賦活抗がん薬)
TOPIC
C1: Disinfectants and antiseptics
消毒薬・防腐薬
TOPIC
C2: Antimycobacterial drugs
抗抗酸菌薬(抗結核薬)
TOPIC
C3: Antiprotozoal and antihelminthic drugs
抗原虫薬・駆虫薬
TOPIC
C4: Antifungal agents
抗真菌薬
TOPIC
C5: Agents to treat Herpes simplex (HSV), varicella-zoster (VZV), cytomegalovirus (CMV). Anti-influenza agents. Drugs against Corona- and other viruses
抗ヘルペス・抗水痘帯状疱疹・抗サイトメガロウイルス薬・抗インフルエンザ薬・抗コロナその他ウイルス薬
TOPIC
C6: Antiretroviral agents
抗レトロウイルス薬
TOPIC
C7: Agents against hepatitis viruses
抗肝炎ウイルス薬
TOPIC
C8: Penicillins
ペニシリン系
TOPIC
C9: Cephalosporins
セファロスポリン系
TOPIC
C10: Carbapenems. Monobactams. Beta-lactamase inhibitors
カルバペネム系・モノバクタム系・βラクタマーゼ阻害薬
TOPIC
C11: Chloramphenicol. Polymyxins. Antifolate drugs
クロラムフェニコール・ポリミキシン・葉酸拮抗薬
TOPIC
C12: Tetracyclines and glycylcyclines
テトラサイクリン系・グリシルサイクリン系
TOPIC
C13: Aminoglycosides
アミノグリコシド系
TOPIC
C14: Quinolones and fluoroquinolones
キノロン系・フルオロキノロン系
TOPIC
C15: Macrolides. Pleuromutilins
マクロライド系・プレウロムチリン系
TOPIC
C16: Clindamycin. Streptogramins. Oxazolidinones. Fusidans
クリンダマイシン・ストレプトグラミン・オキサゾリジノン・フシジン酸系
TOPIC
C17: Glycopeptides. Lipopeptides. Bacitracin. Mupirocin
グリコペプチド・リポペプチド・バシトラシン・ムピロシン
TOPIC
C18: Metronidazole. Fidaxomicin. Rifaximin. Nitrofurantoin. Fosfomycin
メトロニダゾール・フィダキソマイシン・リファキシミン・ニトロフラントイン・ホスホマイシン
TOPIC
Core1: Stages of drug development in brief
薬物開発の段階(概要)
TOPIC
Core2: Types of clinical trials
臨床試験の種類
TOPIC
Core3: History of the Hungarian pharmaceutical industry
ハンガリー製薬産業の歴史
TOPIC
Core4: Molecular targets of drugs
薬物の分子標的
TOPIC
Core5: Receptor theory - agonist, partial agonist, antagonist, inverse agonist
受容体理論：作動薬・部分作動薬・拮抗薬・逆作動薬
TOPIC
Core6: Efficacy, potency
有効性(効力)と力価
TOPIC
Core7: Dose-effect relationships at population level
集団レベルでの用量反応関係
TOPIC
Core8: Adverse drug reactions
薬物有害反応
TOPIC
Core9: Therapeutic index
治療係数
TOPIC
Core10: Tolerance, tachyphylaxis, dependence
耐性・タキフィラキシー・依存
TOPIC
Core11: Absorption of drugs
薬物の吸収
TOPIC
Core12: Membrane transport mechanisms
膜輸送機構
TOPIC
Core13: Distribution of drugs
薬物の分布
TOPIC
Core14: Bioavailability
バイオアベイラビリティ(生物学的利用能)
TOPIC
Core15: Volume of distribution
分布容積
TOPIC
Core16: Phases of drug biotransformation
薬物代謝(生体内変換)の相
TOPIC
Core17: Excretion of drugs
薬物の排泄
TOPIC
Core18: Linear and non-linear pharmacokinetics
線形・非線形薬物動態
TOPIC
Core19: Clearance
クリアランス
TOPIC
Core20: Half-life
半減期
TOPIC
Core21: Saturating and maintenance dose
飽和用量と維持用量
TOPIC
Core22: Drug accumulation and cumulation
薬物の蓄積と累積
TOPIC
Core23: Enzyme inducers
酵素誘導薬
TOPIC
Core24: Enzyme inhibitors
酵素阻害薬
TOPIC
Core25: Pharmacodynamic interactions - synergism
薬力学的相互作用：相乗作用
TOPIC
Core26: Pharmacodynamic interactions - antagonism
薬力学的相互作用：拮抗作用
TOPIC
Core27: Pharmacokinetic drug interactions - at the level of absorption
薬物動態学的相互作用：吸収レベル
TOPIC
Core28: Pharmacokinetic drug interactions - at the level of distribution
薬物動態学的相互作用：分布レベル
TOPIC
Core29: Pharmacokinetic drug interactions - at the level of metabolism
薬物動態学的相互作用：代謝レベル
TOPIC
Core30: Pharmacokinetic drug interactions - at the level of elimination
薬物動態学的相互作用：排泄レベル
TOPIC
Core31: Special groups - drug interactions: pregnancy
特殊集団-薬物相互作用：妠娠
TOPIC
Core32: Special groups - drug interactions: childhood
特殊集団-薬物相互作用：小児
TOPIC
Core33: Special groups - drug interactions: ageing
特殊集団-薬物相互作用：加齢
TOPIC
Core34: Characterisation of biological medicinal products
生物学的医薬品の特性
TOPIC
Core35: Orphan drugs
オーファンドラッグ(希少疾病用医薬品)
TOPIC
Core36: Advanced therapy medicinal products. Vaccines
先端治療医薬品・ワクチン
TOPIC
Core37: Nutritional supplements
栄養補助食品(サプリメント)
TOPIC
Core38: Traditional herbal active substances
伝統的生薬有効成分
TOPIC
Core39: Medical device
医療機器
TOPIC
Core40: Principles of antimicrobial treatment - selective toxicity
抗菌薬治療の原則：選択毒性
TOPIC
Core41: Principles of antimicrobial treatment - empirical, targeted and prophylactic therapy
抗菌薬治療の原則：経験的・標的・予防的治療
TOPIC
Core42: Principles of antimicrobial treatment - bactericidal, bacteriostatic antibiotics and antibiotic combinations
抗菌薬治療の原則：殺菌性・静菌性抗菌薬と抗菌薬併用
TOPIC
Core43: Principles of antimicrobial treatment - time-, concentration- and exposure-dependent antibiotics
抗菌薬治療の原則：時間・濃度・曝露依存性抗菌薬
TOPIC
Core44: Narrow and broad spectrum antibiotics
狭域・広域抗菌薬
TOPIC
Core45: Antibiotic selection considerations - pregnancy, childhood
抗菌薬選択の考慮事項：妠娠・小児
TOPIC
Core46: Antibiotic selection considerations - infections affecting specific compartments
抗菌薬選択の考慮事項：特定部位の感染症
TOPIC
Core47: Considerations for antibiotic choice - comorbidities
抗菌薬選択の考慮事項：併存疾患
TOPIC
Core48: Antidote - definition and examples
解毒薬：定義と例
TOPIC
Core49: Pharmacogenetics, pharmacogenomics - definition, examples
薬理遺伝学・薬理ゲノム学：定義と例
TOPIC
Core50: Classification of drugs according to chemical structure and complexity
化学構造と複雑さによる薬物分類
TOPIC
Core51: Drug-induced adverse reaction: sulfonamide allergy and its characterization
薬剤性有害反応：スルホンアミドアレルギーとその特徴
TOPIC
Core52: Drug-induced adverse reaction: serotonin syndrome
薬剤性有害反応：セロトニン症候群
TOPIC
Core53: Drug-induced adverse reaction: neuroleptic malignant syndrome
薬剤性有害反応：悪性症候群
TOPIC
Core54: Drug-induced adverse reaction: Stevens-Johnson syndrome
薬剤性有害反応：スティーブンス・ジョンソン症候群
TOPIC
Core55: Drug-induced adverse reaction: pseudomembranous colitis
薬剤性有害反応：偽膜性大腸炎
TOPIC
Core56: Drug-induced adverse reaction: cheese reaction
薬剤性有害反応：チーズ反応
TOPIC
Core57: Drug-induced adverse reaction: orthostatic hypotension
薬剤性有害反応：起立性低血圧
TOPIC
Core58: Drug-induced adverse reaction: hemorrhage
薬剤性有害反応：出血
TOPIC
Core59: Drug-induced adverse reaction: thrombosis
薬剤性有害反応：血栓症
TOPIC
Core60: Drug-induced adverse reaction: bone marrow damage
薬剤性有害反応：骨髄障害
TOPIC
Core61: Drug-induced adverse reaction: nephrotoxicity
薬剤性有害反応：腗毒性
TOPIC
Core62: Drug-induced adverse reaction: ototoxicity
薬剤性有害反応：聴器毒性
TOPIC
Core63: Drug-induced adverse reaction: hepatotoxicity
薬剤性有害反応：肝毒性
TOPIC
Core64: Drug-induced adverse reaction: QT prolongation
薬剤性有害反応：QT延長
TOPIC
Core65: Drug-induced adverse reaction: bradycardia / AV block
薬剤性有害反応：徐脈・房室ブロック
TOPIC
Core66: Drug-induced adverse reaction: constipation, diarrhea, vomiting
薬剤性有害反応：便秘・下痢・嘔吐
TOPIC
Core67: Drug-induced adverse reaction: mucosal damage
薬剤性有害反応：粘膜障害
TOPIC
Core68: Drug-induced adverse reaction: weight gain/loss
薬剤性有害反応：体重増加・減少
TOPIC
Core69: Drug-induced adverse reaction: sedation
薬剤性有害反応：鏮静
TOPIC
Core70: Drug-induced adverse reaction: epileptiform seizures
薬剤性有害反応：てんかん性発作
TOPIC
Core71: Drug-induced adverse reaction: sexual dysfunction
薬剤性有害反応：性機能障害
TOPIC
Core72: Drug-induced adverse reaction: dental and oral cavity adverse reactions
薬剤性有害反応：歯・口腔の有害反応
TOPIC
Core73: The Summary of Product Characteristics
製品概要(添付文書/SmPC)